Clinical trial
Combination Chemotherapy in Treating Patients With Advanced Cancer
NCT00003331 · NYU Langone Health, Other · Completed
Key facts
| NCT number | NCT00003331 |
|---|---|
| Title | Combination Chemotherapy in Treating Patients With Advanced Cancer |
| Official title | A Phase I Study of Low Dose Continuous Infusion Topotecan in Combination With 5-Fluorouracil and Leucovorin for Advanced Malignancies |
| Lead sponsor | NYU Langone Health, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Precancerous Condition, Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | fluorouracil, leucovorin calcium, topotecan hydrochloride |
| Enrollment | 30 |
| Start date | Jan 1, 1998 |
| Primary completion | Nov 1, 2001 |
| First posted | Sep 13, 2004 |
| Last update posted | Mar 28, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: